Stock Information
United Therapeutics Corp (UTHR)
Ticker Symbol: UTHR
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $23,496.90 mil
Piotroski score: 5
PE Ratio: 19.1783
EPS (TTM): 27.9001
Revenue (TTM): $67.29 M
Dividend Yield: N/A%
ROE: 19.3%
Latest News
-
UTHR Stock Rises 12.5% on Promising Data From TETON-1 Tyvaso Study
Tue, Mar 31, 2026 4:05 PM
-
Assessing United Therapeutics (UTHR) Valuation After Positive Tyvaso Phase 3 IPF Trial Results
Tue, Mar 31, 2026 2:07 PM
-
United Therapeutics Gets Dual Target Hikes From BofA and Wells Fargo
Tue, Mar 31, 2026 1:13 PM
-
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Tue, Mar 31, 2026 1:00 PM
-
US Stock Market Today S&P 500 Futures Rise On Fed Caution And Bond Jitters
Tue, Mar 31, 2026 10:07 AM
-
United Therapeutics (UTHR) Moves 12.5% Higher: Will This Strength Last?
Tue, Mar 31, 2026 9:08 AM
-
B of A Securities Maintains Neutral on United Therapeutics, Raises Price Target to $626
Tue, Mar 31, 2026 8:54 AM
-
Insmed (INSM) Soars 5.5%: Is Further Upside Left in the Stock?
Tue, Mar 31, 2026 6:46 AM
-
Chips Down, Ackman Up: How Iran, the Fed, and a Viral Post Defined Monday's Market
Tue, Mar 31, 2026 5:32 AM
-
Why United Therapeutics (UTHR) Stock Is Up Today
Mon, Mar 30, 2026 9:58 PM
Key Financials
Financial data not available
